3 Stocks in Focus: Las Vegas Sands Corp. (LVS), Mead Johnson Nutrition Company (MJN), Cabot Oil & Gas Corporation (COG)

Las Vegas Sands Corp. (LVS) fell -0.92% during last trading as the stock lost $-0.49 to finish the day at $52.51 with about 4.67M shares changing hands, compared to its three month average trading volume of 4.83M. The $41.89B market cap company, which fluctuated between $52.13 and $53.1 during the day, currently situated 29.93% above its 52 week low of $41.25 and -16.09% away from its one year high of $63.38. The RSI of 40.38 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, Sands Cotai Central, the Four Seasons Hotel Macao, Cotai Strip, the Plaza Casino, and the Sands Macao in Macao, the People’s Republic of China; and iconic Marina Bay Sands in Singapore. The company also owns and operates The Venetian Resort Hotel Casino, The Palazzo Resort Hotel Casino, and Five-Diamond luxury resorts on the Las Vegas Strip; Sands Expo and Convention Center in Las Vegas, Nevada; and the Sands Casino Resort Bethlehem in Bethlehem, Pennsylvania. Its integrated resorts include accommodations, gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.

Mead Johnson Nutrition Company (MJN) dropped $-0.08 to close the day at a new closing price of $87.6, a -0.09% decrease in value from its previous closing price that moved the stock 26.56% above its 52 week low of $69.25. A total of 4.67M shares exchanged hands during the day compared with its three month average trading volume of 3.28M. The stock, which fluctuated between $87.6 and $87.89 during the day, currently situated -6.17% below its 52 week high. The stock is up by 16.41% in the past one month and up by 23.02% over the past three months. With a one year target estimate of $81.7 and RSI of 74.88, the stock still has upside potential, making it a sell for now.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Cabot Oil & Gas Corporation (COG) had a light trading with around 4.64M shares changing hands compared to its three month average trading volume of 6.68M. The stock traded between $23.03 and $24.04 before closing at the price of $23.12 with -3.22% change on the day. The Houston Texas 77024 based company is currently trading 25.55% above its 52 week low of $18.73 and -13.38% below its 52 week high of $26.74. Both the RSI indicator and target price of 52.49 and $28.34 respectively, lead us to believe that it should be put on hold over the coming weeks.

Cabot Oil & Gas Corporation, an independent oil and gas company, develops, exploits, explores for, produces, and markets natural gas, oil, and natural gas liquids in the United States. The company primarily focuses on the Marcellus Shale in northeast Pennsylvania with approximately 200,000 net acres in the dry gas window of the play; and the Eagle Ford Shale in south Texas with approximately 85,500 net acres in the oil window of the play. It also transports, stores, gathers, and purchases natural gas for resale. The company sells its natural gas to industrial customers, local distribution companies, and gas marketers through gathering systems and pipelines, as well as to intrastate pipelines, natural gas processors, and marketing companies. As of December 31, 2015, it had proved reserves of approximately 8,190 billion cubic feet of natural gas equivalent. The company was founded in 1989 and is headquartered in Houston, Texas.

 

Stocks Alert: Mead Johnson Nutrition Company (MJN), Pfizer Inc. (PFE), Nielsen Holdings plc (NLSN)

Mead Johnson Nutrition Company (MJN) retreated with the stock falling -0.18% or $-0.16 to close at $88.04 on active trading volume of 7.87M compared its three months average trading volume of 3.06M. The Glenview Illinois 60026 based company operating under the Processed & Packaged Goods industry has been trending up for the last 52 weeks, with the shares price now 23.31% up for the period and up by 24.42% so far this year. With price target of $81.7 and a 27.13% rebound from 52-week low, Mead Johnson Nutrition Company has plenty of upside potential, making it a hold with a view buy.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Pfizer Inc. (PFE) gained $0.14 to close the day at a new closing price of $32.75, a 0.43% increase in value from its previous closing price that moved the stock 18.28% above its 52 week low of $28.74. A total of 22.89M shares exchanged hands during the day compared with its three month average trading volume of 24.94M. The stock, which fluctuated between $32.35 and $32.77 during the day, currently situated -9.89% below its 52 week high. The stock is up by 1.73% in the past one month and up by 1.51% over the past three months. With a one year target estimate of $37.48 and RSI of 65, the stock still has upside potential, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, Transgene S.A., Edelris SAS, IGNITE Immunotherapy Inc., and AbCellera Biologics Inc.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Nielsen Holdings plc (NLSN) shares were down in last trading by -0.47% to $44.77. It experienced higher than average volume on day. The stock increased in value by almost 6.95% over the past week and grew 5.69% in the past month. It is currently trading 6.05% above its 50 day moving average and -8.19% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -18.93% decrease in value from its one year high of $55.94. The RSI indicator value of 71.11, lead us to believe that it may reverse gains in the near term.

Nielsen Holdings plc operates as an information and measurement company. The company provides media and marketing information, analytics, and manufacturer and retailer expertise about what and where consumers buy, read, watch and listen. Its Buy segment provides retail transactional measurement data, consumer behavior information, and analytics primarily to businesses in the consumer packaged goods industry. This segment provides data on retail measurement services, such as market share and competitive sales volumes; insights into distribution, pricing, merchandising, and promotion; consumer panel measurement, which offers insight into shopper behavior and customer segmentation; and consumer intelligence and analytical services for decision making in development and marketing cycles. The company’s Watch segment provides viewership and listening data, and analytics primarily to the media and advertising industries for television, radio, digital and mobile viewing, and listening platforms. It offers television audience measurement services, including more than one screen, unduplicated reach, cause and effect analysis, and program viewing behavior testing; audio audience measurement services; digital audience measurement services, such as digital media and market research, audience analytics, and social media measurement; mobile measurement services comprising measurement and consumer research for telecom and media companies; and advertiser solutions. The company was formerly known as Nielsen N.V. and changed its name to Nielsen Holdings plc in August 2015. The company was founded in 1923 and is headquartered in Oxford, the United Kingdom.

 

3 Stocks in Focus: Activision Blizzard, Inc. (ATVI), Mead Johnson Nutrition Company (MJN), Freeport-McMoRan Inc. (FCX)

Activision Blizzard, Inc. (ATVI) climbed 18.88% during last trading as the stock added $7.5 to finish the day at $47.23 with about 51.7M shares changing hands, compared to its three month average trading volume of 8.29M. The $35.14B market cap company, which fluctuated between $44.93 and $47.64 during the day, currently situated 79.74% above its 52 week low of $28.55 and 3.69% away from its one year high of $47.64. The RSI of 84.49 indicates the stock is overbought at the current levels, sell for now.

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games. The company operates through two segments, Activision Publishing, Inc. and Blizzard Entertainment, Inc. The company develops, publishes, and sells interactive software products and content through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes subscription-based massively multiplayer online role-playing games; and strategy and role-playing games. In addition, the company maintains a proprietary online gaming service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it engages in creating original film and television content; and provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases in the United States, Canada, Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, the Netherlands, Australia, South Korea, China, and internationally. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

Mead Johnson Nutrition Company (MJN) gained $4.67 to close the day at a new closing price of $87.72, a 5.62% increase in value from its previous closing price that moved the stock 30.69% above its 52 week low of $69.25. A total of 50.31M shares exchanged hands during the day compared with its three month average trading volume of 2.23M. The stock, which fluctuated between $86.95 and $87.84 during the day, currently situated -6.04% below its 52 week high. The stock is up by 24.58% in the past one month and up by 18.89% over the past three months. With a one year target estimate of $81.7 and RSI of 76.75, the stock still has upside potential, making it a sell for now.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Freeport-McMoRan Inc. (FCX) had a active trading with around 45.36M shares changing hands compared to its three month average trading volume of 32.22M. The stock traded between $15.74 and $16.56 before closing at the price of $15.8 with 2.66% change on the day. The Phoenix Arizona 85004 based company is currently trading 239.78% above its 52 week low of $5.8 and -7.39% below its 52 week high of $17.06. Both the RSI indicator and target price of 50.26 and $14.76 respectively, lead us to believe that it should be put on hold over the coming weeks.

Freeport-McMoRan Inc., a natural resource company, acquires, explores, and develops mineral assets, and oil and natural gas resources. The company explores for copper, gold, molybdenum, cobalt hydroxide, silver, and other metals, as well as oil and gas. It holds interests in various mines located in the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, Miami, Chino, Tyrone, Henderson, and Climax in North America; Cerro Verde and El Abra in South America; and the Tenke Fungurume minerals district in the Democratic Republic of Congo, Africa. The company’s oil and gas operations include oil production facilities in the Deepwater Gulf of Mexico; oil production facilities onshore and offshore in California; onshore natural gas resources in the Haynesville shale in Louisiana; natural gas production from the Madden area in central Wyoming; and a position in the Inboard Lower Tertiary/Cretaceous natural gas trend onshore located in South Louisiana. As of December 31, 2015, its consolidated recoverable proven and probable mineral reserves included 99.5 billion pounds of copper, 27.1 million ounces of gold, 3.05 billion pounds of molybdenum, 271.2 million ounces of silver, and 0.87 billion pounds of cobalt; and its estimated proved oil and natural gas reserves totaled 252 million barrels of oil equivalents. The company was formerly known as Freeport-McMoRan Copper & Gold Inc. and changed its name to Freeport-McMoRan Inc. in July 2014. Freeport-McMoRan Inc. was founded in 1987 and is headquartered in Phoenix, Arizona.

 

Three Movers to Watch for: Mead Johnson Nutrition Company (MJN), Church & Dwight Co., Inc. (CHD), Apache Corporation (APA)

Mead Johnson Nutrition Company (MJN) grew with the stock adding 0.14% or $0.12 to close at $83.96 on active trading volume of 3.13M compared its three months average trading volume of 2.31M. The Glenview Illinois 60026 based company operating under the Processed & Packaged Goods industry has been trending up for the last 52 weeks, with the shares price now 26.3% up for the period and up by 18.65% so far this year. With price target of $78 and a 28.69% rebound from 52-week low, Mead Johnson Nutrition Company has plenty of upside potential, making it a hold with a view buy.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Church & Dwight Co., Inc. (CHD) gained $0.56 to close the day at a new closing price of $47.83, a 1.18% increase in value from its previous closing price that moved the stock 14.04% above its 52 week low of $42.42. A total of 3.11M shares exchanged hands during the day compared with its three month average trading volume of 2.07M. The stock, which fluctuated between $47.29 and $48.05 during the day, currently situated -10.22% below its 52 week high. The stock is up by 7.97% in the past one month and up by 8.09% over the past three months. With a one year target estimate of $46.77 and RSI of 73.56, the stock still has upside potential, making it a sell for now.

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products in the United States. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division (SPD). The Consumer Domestic segment offers household products, such as baking soda, carpet and cat litter deodorizers, clumping cat litters, washing soda, fabric softeners, daily shower cleaners, cleaning products, dishwashing detergents and boosters, laundry and cleaning solutions, and bathroom cleaners, as well as powder, liquid, and unit dose laundry detergents; and personal care products comprising toothpastes and oral rinses, home pregnancy and ovulation test kits, deodorants and antiperspirants, toothbrushes, shampoos, dietary supplements, depilatories, lotions, creams, waxes, oral analgesics, nasal saline moisturizers, and feminine hygiene products, as well as condoms, lubricants, and vibrating products. The Consumer International segment sells personal care, household, and over-the-counter products in international markets, such as Canada, France, Australia, China, the United Kingdom, Mexico, and Brazil. The SPD segment offers animal nutrition products, including feed grade sodium bicarbonate, rumen fermentation enhancers, feed grade potassium carbonate, rumen bypass fat and lysine, omega 3 and 6 essential fatty acids, natural sodium sesquicarbonate, and refined functional carbohydrate; and specialty chemicals, such as performance grade sodium bicarbonate, and potassium carbonate and bicarbonate. It also provides specialty cleaners, such as aqueous cleaners and deodorizers for commercial and industrial applications. The company sells its products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and pet stores, and other specialty stores, as well as through Websites. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.

Apache Corporation (APA) shares were down in last trading by -0.18% to $56.93. It experienced lighter than average volume on day. The stock decreased in value by almost -1.47% over the past week and fell -8.34% in the past month. It is currently trading -10.1% below its 50 day moving average and -1.61% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -17.16% decrease in value from its one year high of $69. The RSI indicator value of 29.25, lead us to believe that it may correct downwards in the near term.

Apache Corporation, an independent energy company, explores, develops, and produces natural gas, crude oil, and natural gas liquids. It operates onshore and offshore assets primarily in the Permian Basin, the Anadarko basin in western Oklahoma, the Texas Panhandle, and Gulf Coast areas of the United States, as well as in Western Canada and Gulf of Mexico. The company also operates assets in Egypt and the United Kingdom in the North Sea. As of December 31, 2015, it had total estimated proved reserves of 794 million barrels of crude oil, 198 million barrels of natural gas liquids, and 3.4 trillion cubic feet of natural gas. Apache Corporation was founded in 1954 and is based in Houston, Texas.

 

3 Stocks to Watch For: The Kroger Co. (KR), Mead Johnson Nutrition Company (MJN), United Technologies Corporation (UTX)

The Kroger Co. (KR) saw its value decrease by -0.97% as the stock dropped $-0.33 to finish the day at a closing price of $33.69. The stock was lighter in trading and has fluctuated between $28.71-$40.91 per share for the past year. The shares, which traded within a range of $33.64 to $34.09 during the day, are up by 9.01% in the past three months and up by 4.05% over the past six months. It is currently trading -0.12% below its 20 day moving average and -0.97% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $36 a share over the next twelve months. The current relative strength index (RSI) reading is 49.88.The technical indicator lead us to believe there will be no major movement any time soon, hold.

The Kroger Co., together with its subsidiaries, operates as a retailer in the United States. It also manufactures and processes food for sale in its supermarkets. The company operates retail food and drug stores, multi-department stores, jewelry stores, and convenience stores. Its combination food and drug stores offer natural food and organic sections, pharmacies, general merchandise, pet centers, fresh seafood, and organic produce; multi-department stores provide general merchandise items, such as apparel, home fashion and furnishings, outdoor living, electronics, automotive products, toys, and fine jewelry; and price impact warehouse stores offer grocery, and health and beauty care items, as well as meat, dairy, baked goods, and fresh produce items. The company’s marketplace stores comprise full-service grocery, pharmacy, health and beauty departments, and perishable goods, as well as general merchandise, including apparel, home goods, and toys. It operates under the banner brands, such as Kroger, Ralphs, Fred Meyer, King Soopers, etc., as well as Simple Truth and Simple Truth Organic brands. As of January 30, 2016, the company operated 2,778 retail food stores, including 1,387 fuel centers; 784 convenience stores; and 323 fine jewelry stores and an online retail store, as well as franchised 78 convenience stores. The Kroger Co. was founded in 1883 and is headquartered in Cincinnati, Ohio.

Mead Johnson Nutrition Company (MJN) shares were down in last trading by -0.25% to $83.87. It experienced higher than average volume on day. The stock increased in value by almost 19.59% over the past week and grew 17.02% in the past month. It is currently trading 15.93% above its 50 day moving average and 5.27% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -10.16% decrease in value from its one year high of $94.4. The RSI indicator value of 73.83, lead us to believe that it may reverse gains in the near term.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

United Technologies Corporation (UTX) traded within a range of $109.68 to $111.25 after opening the day at $109.81. The company has seen its stock increase in value by 0.97% so far this year. The stock was up close to 0.94% on active volume in last trading session and closed at $110.68 per share. After the recent gain, the stock is currently holding -1.91% below its 52 week high of $112.83 and 35.51% above its 12-month low of $83.85. The shares are up by over 10.21% in the last three months, and the RSI indicator value of 54.83 is neither bullish nor bearish, tempting investors to stay on the sidelines.

United Technologies Corporation provides technology products and services to building systems and aerospace industries worldwide. Its Otis segment designs, manufactures, sells, and installs passenger and freight elevators, escalators, and moving walkways; modernization products to upgrade elevators and escalators; and maintenance and repair services. The company’s UTC Climate, Controls & Security segment provides heating, ventilating, air conditioning, and refrigeration solutions, such as controls for residential, commercial, industrial, and transportation applications. This segment offers electronic security products, including intruder alarms, access control systems, and video surveillance systems; and fire safety products; systems integration, video surveillance, installation, maintenance, and inspection services; and monitoring and response services. Its Pratt & Whitney segment supplies aircraft engines for commercial, military, business jet, and general aviation markets; and provides aftermarket maintenance, repair, and overhaul, as well as fleet management services. The company’s UTC Aerospace Systems segment provides electric power generation, power management, and distribution systems; air data, and flight sensing and management systems; engine control, electric, intelligence, surveillance, and reconnaissance systems; engine components; environmental control systems; fire and ice detection, and protection systems; propeller systems; cargo, actuation, and landing systems; aircraft aero structures, and lighting and seating products; space products and subsystems; and aftermarket services. United Technologies Corporation offers its services through manufacturers’ representatives, distributors, wholesalers, dealers, retail outlets, and sales representatives, as well as directly to customers. The company was founded in 1934 and is headquartered in Farmington, Connecticut.

 

Three Movers to Watch for: Mead Johnson Nutrition Company (MJN), Pfizer Inc. (PFE), General Electric Company (GE)

Mead Johnson Nutrition Company (MJN) grew with the stock adding 21.41% or $14.88 to close at $84.38 on active trading volume of 24.46M compared its three months average trading volume of 1.84M. The Glenview Illinois 60026 based company operating under the Processed & Packaged Goods industry has been trending up for the last 52 weeks, with the shares price now 25.07% up for the period and up by 19.25% so far this year. With price target of $76.67 and a 29.33% rebound from 52-week low, Mead Johnson Nutrition Company has plenty of upside potential, making it a hold with a view buy.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Pfizer Inc. (PFE) gained $0.06 to close the day at a new closing price of $31.73, a 0.19% increase in value from its previous closing price that moved the stock 16.58% above its 52 week low of $28.25. A total of 23.36M shares exchanged hands during the day compared with its three month average trading volume of 28.21M. The stock, which fluctuated between $31.32 and $31.73 during the day, currently situated -12.7% below its 52 week high. The stock is down by -2.87% in the past one month and up by 4.19% over the past three months. With a one year target estimate of $37.52 and RSI of 51.72, the stock still has upside potential, making it a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

General Electric Company (GE) shares were down in last trading by -0.03% to $29.68. It experienced lighter than average volume on day. The stock decreased in value by almost -2.11% over the past week and fell -6.34% in the past month. It is currently trading -4.94% below its 50 day moving average and -2.55% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -9.36% decrease in value from its one year high of $33. The RSI indicator value of 28.84, lead us to believe that it may correct downwards in the near term.

General Electric Company operates as an infrastructure and financial services company worldwide. Its Power segment offers gas and steam power systems; maintenance, service, and upgrade solutions; distributed power gas engines; water treatment, wastewater treatment, and process system solutions; and nuclear reactors, fuels, and support services. The company’s Renewable Energy segment offers wind turbine platforms, and hardware and software; offshore wind turbines; and solutions, products, and services to hydropower industry. Its Oil and Gas segment offers turbomachinery solutions; surface and subsea drilling and production systems, and equipment for floating production platforms; measurement and control products; and compressors, pumps, valves, and natural gas solutions. The company’s Energy Management segment offers industrial and grid solutions, and power conversion systems. Its Aviation segment designs and produces commercial and military aircraft engines, integrated digital components, electric power, and mechanical aircraft systems; and offers aftermarket services. The company’s Healthcare segment offers diagnostic imaging and clinical systems; products for drug discovery, biopharmaceutical manufacturing, and cellular technologies; and healthcare information technology products. Its Transportation segment offers freight and passenger locomotives, parts, wreck repair, software-enabled solutions, mining equipment and services, marine diesel engines, and stationary power diesel engines and motors, as well as overhaul, repair, and upgrade services. GE’s Appliances & Lighting segment sells and services home appliances; and manufactures, sources, and sells lighting solutions. Its Capital segment offers commercial lending and leasing, factoring, energy financial, and aircraft financing and leasing services. GE also designs powder bed-based laser additive manufacturing machines. The company was founded in 1892 and is headquartered in Fairfield, Connecticut.

 

Stocks Intraday Alert: Mead Johnson Nutrition Company (MJN), E. I. du Pont de Nemours and Company (DD), Lowe’s Companies, Inc. (LOW)

Mead Johnson Nutrition Company (MJN) managed to rebound with the stock climbing 0.47% or $0.33 to close the day at $70.46 on higher than average trading volume of 1.96M shares, compared to its three month average trading volume of 1.87M. The Glenview Illinois 60026 based company has been outperforming the processed & packaged goods companies by -7.0265% for last three months and its recent losses have pulled the stock down -0.42% YTD, versus the processed & packaged goods industry which is up 1.27% for the same period. The RSI of 40.74 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

  1. I. du Pont de Nemours and Company (DD) had a light trading with around 1.97M shares changing hands compared to its three month average trading volume of 2.91M. The stock traded between $75.04 and $75.87 before closing at the price of $75.5 with -0.66% change on the day. The Wilmington Delaware 19805 based company is currently trading 49.64% above its 52 week low of $55.94 and -3.65% below its 52 week high of $78.36. Both the RSI indicator and target price of 54.53 and $79.31 respectively, lead us to believe that it should be put on hold over the coming weeks.
  2. I. du Pont de Nemours and Company operates as a science and technology based company. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, rice, seed products, herbicides, fungicides, and insecticides, as well as offers crop protection products, such as weed control, disease control, and insect control products. Its Electronics & Communications segment provides various materials and systems, including photopolymers and electronic materials for photovoltaic, consumer electronics, displays, and advanced printing. The company’s Industrial Biosciences segment develops and manufactures a portfolio of enzymes and bio-based materials. Its Nutrition & Health segment offers cultures, probiotics, texturants, emulsifiers, natural sweeteners, and soy-based food ingredients for the food industry market. The company’s Performance Materials segment offers elastomers and thermoplastic, and thermoset engineering polymers; resins and films for packaging and industrial polymer applications, sealants and adhesives, and sporting goods; and elastomers, parts, and systems and solutions for automotive and transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor, and aerospace markets. Its Safety & Protection segment provides nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The company markets its products through the company’s sales force and distributors in the United States and internationally. E. I. du Pont de Nemours and Company was founded in 1802 and is headquartered in Wilmington, Delaware.

Lowe’s Companies, Inc. (LOW) traded within a range of $72.75 to $73.54 after opening the day at $72.84. The company has seen its stock increase in value by 3.26% so far this year. The stock was down close to -0.67% on light volume in last trading session and closed at $73.08 per share. After the recent fall, the stock is currently holding -11.4% below its 52 week high of $83.65 and 18.79% above its 12-month low of $62.62. The shares are up by over 9.56% in the last three months, and the RSI indicator value of 58.06 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Lowe’s Companies, Inc. operates as a home improvement retailer. It offers products for home maintenance, repair, remodeling, and decorating. The company provides home improvement products in various categories, such as lumber and building materials, tools and hardware, appliances, fashion fixtures, rough plumbing and electrical, lawn and garden, seasonal living, paint, flooring, millwork, kitchens, outdoor power equipment, and home fashions. It also offers installation services through independent contractors in various product categories; extended protection plans; and in-warranty and out-of-warranty repair services. The company sells its national brand-name merchandise and private branded products to homeowners, renters, and professional customers; and retail customers comprising individual homeowners and renters. As of January 29, 2016, it operated 1,857 home improvement and hardware stores in the United States, Canada, and Mexico. The company also sells its products through online sites comprising Lowes.com, Lowes.ca, and ATGstores.com, as well as through mobile applications. Lowe’s Companies, Inc. was founded in 1946 and is based in Mooresville, North Carolina.

 

Traders Recap: Mead Johnson Nutrition Company (MJN), KKR & Co. L.P. (KKR), Vertex Pharmaceuticals Incorporated (VRTX)

Mead Johnson Nutrition Company (MJN) continued its downward trend with the stock declining -2.46% or $-1.8 to close the day at $71.24 on lower than average trading volume of 1.91M shares, compared to its three month average trading volume of 1.93M. The Glenview Illinois 60026 based company has been outperforming the processed & packaged goods companies by -11.0996% for last three months and its recent losses have trimmed gains to 0.68% YTD, versus the processed & packaged goods industry which is up 1.48% for the same period. The RSI of 43.48 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

KKR & Co. L.P. (KKR) had a light trading with around 1.87M shares changing hands compared to its three month average trading volume of 2.78M. The stock traded between $17.68 and $17.8 before closing at the price of $17.74 with -0.34% change on the day. The New York New York 10019 based company is currently trading 70.84% above its 52 week low of $10.89 and -0.67% below its 52 week high of $17.86. Both the RSI indicator and target price of 69.94 and $19.32 respectively, lead us to believe that it should be put on hold over the coming weeks.

KKR & Co. L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the Upstream Oil and Gas and Equipment and Services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and mining; energy and natural resources; financial services; healthcare; industrials; media and communications; retail; and technology. Within Europe, the firm invests in consumer and retail; energy; financial services; health care; industrials and chemicals; media and digital; and telecom and technologies. Within Asia, it invests in consumer products; energy and resources; financial services; healthcare; industrials; logistics; media and telecom; retail; real estate; and technology. The firm seeks to invest in mid to high-end residential developments, but can invest in other projects throughout Mainland China through outright ownership, joint ventures, and merger. It invests globally with a focus on Australia, emerging and developed Asia, Middle East and Africa, Nordic, Southeast Asia, Asia Pacific, Ireland, Hong Kong, Japan, Taiwan, India, Vietnam, Indonesia, France, Germany, Netherlands, United Kingdom, Caribbean, Mexico, South America, North America, Brazil, Latin America, Korea, and United States of America. In the United States and Europe, the firm focuses on buyouts of large, publicly traded companies. It seeks to invest $30 million to $717 million in companies with enterprise values between $500 million to $2389 million. The firm prefers to invest in a range of debt and public equity investing and may co-invest. It seeks a board seat in its portfolio companies and a controlling ownership of a company or a strategic minority positions. The firm may acquire minority equity interests, particularly when making private equity investments in Asia or sponsoring investments as part of a large investor consortium. The firm typically holds its investment for a period of five to seven years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. KKR & Co. L.P. was founded in 1976 and is based in New York, New York with additional offices across North America, Europe, Australia, and Asia.

Vertex Pharmaceuticals Incorporated (VRTX) traded within a range of $85.1 to $87.5 after opening the day at $85.62. The company has seen its stock increase in value by 18.6% so far this year. The stock was up close to 2.39% on light volume in last trading session and closed at $87.37 per share. After the recent gain, the stock is currently holding -15.77% below its 52 week high of $103.73 and 22.26% above its 12-month low of $71.46. The shares are up by over 11% in the last three months, and the RSI indicator value of 66.52 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their CFTR gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 6 years of age and older who have the G551D mutation in their CFTR gene. The company also develops VX-661, a corrector compound that is in a Phase III development stage in combination with ivacaftor in multiple CF patients; VX-371, an investigational epithelial sodium channel, which is in a Phase II development stage; and VX-152 and VX-440 that are CFTR corrector compounds in Phase I clinical trial. In addition, it engages in the research and mid-and early-stage development programs in the areas of oncology, pain, and neurology. The company sells its products primarily to specialty pharmacy providers and wholesalers in North America, as well as government-owned and supported customers in international markets. Vertex Pharmaceuticals Incorporated has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; Parion Sciences, Inc.; CRISPR Therapeutics AG; BioAxone Biosciences, Inc.; Janssen Pharmaceuticals, Inc.; and Moderna Therapeutics, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.

 

3 Trending Stocks: Automatic Data Processing, Inc. (ADP), United Parcel Service, Inc. (UPS), Mead Johnson Nutrition Company (MJN)

Automatic Data Processing, Inc. (ADP) failed to extend gains with the stock declining -0.52% or $-0.54 to close the day at $102.7 on light trading volume of 1.98M shares, compared to its three month average trading volume of 2.07M. The Roseland New Jersey 07068 based company has been outperforming the business software & services group over the past 52 weeks, with the stock gaining 30.07%, compared to the industry which has advanced 23.75% over the same period. With RSI of 55.11, the stock should still continue to rise and get closer to its one year target estimate of $98.63, making it a hold for now.

Automatic Data Processing, Inc., together with its subsidiaries, provides business process outsourcing services worldwide. The company operates through two segments, Employer Services and Professional Employer Organization (PEO) Services. The Employer Services segment offers a range of business outsourcing and technology-enabled human capital management (HCM) solutions, including payroll services, benefits administration services, talent management, human resources management solutions, time and attendance management solutions, insurance services, retirement services, and tax and compliance solutions. This segment’s integrated HCM solutions include RUN Powered by ADP, ADP Workforce Now, ADP Vantage HCM, and ADP GlobalView, which assist employers of all sizes in all stages of the employment cycle from recruitment to retirement; and ADP SmartCompliance and ADP Health Compliance. The PEO Services segment provides a human resources (HR) outsourcing solution through a co-employment model to small and mid-sized businesses. This segment offers ADP TotalSource that provides various HR management services and employee benefits functions, such as HR administration, employee benefits, and employer liability management into a single-source solution. The company was founded in 1949 and is headquartered in Roseland, New Jersey.

United Parcel Service, Inc. (UPS) climbed 0.81% during last trading as the stock added $0.94 to finish the day at $116.99 with about 1.93M shares changing hands, compared to its three month average trading volume of 2.55M. The $101.48B market cap company, which fluctuated between $115.87 and $117.13 during the day, currently situated 35.16% above its 52 week low of $90.26 and -2.86% away from its one year high of $120.44. The RSI of 60.88 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight. The U.S. Domestic Package segment offers time-definite delivery of letters, documents, small packages, and palletized freight through air and ground services in the United States. The International Package segment provides guaranteed day and time-definite international shipping services in Europe, the Asia Pacific, Canada and Latin America, the Indian sub-continent, the Middle East, and Africa. It offers guaranteed time-definite express options, including Express Plus, Express, and Express Saver. The Supply Chain & Freight segment offers international air and ocean freight forwarding, customs brokerage, truckload freight brokerage, distribution and post-sales services, and mail and consulting services in approximately 220 countries and territories; and less-than-truckload and truckload services to customers in North America. The company also offers shipping, visibility, and billing technologies; and insurance, financing, and payment services. It operates a fleet of approximately 110,000 package cars, vans, tractors, and motorcycles; and owns 33,000 containers used to transport cargo in its aircraft. United Parcel Service, Inc. was founded in 1907 and is headquartered in Atlanta, Georgia.

Mead Johnson Nutrition Company (MJN) saw its value decrease by 0% as the stock dropped $0 to finish the day at a closing price of $74.92. The stock was lighter in trading and has fluctuated between $65.53-$94.4 per share for the past year. The shares, which traded within a range of $74.54 to $75.5 during the day, are down by -4.95% in the past three months and down by -18.54% over the past six months. It is currently trading 3.9% above its 20 day moving average and 4.35% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $78.75 a share over the next twelve months. The current relative strength index (RSI) reading is 66.16. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

 

Eye Catching Stocks: Tesoro Corporation (TSO), Mead Johnson Nutrition Company (MJN), Atwood Oceanics, Inc. (ATW)

Tesoro Corporation (TSO) failed to extend gains with the stock declining -1.31% or $-1.07 to close the day at $80.56 on active trading volume of 2.55M shares, compared to its three month average trading volume of 2.35M. The San Antonio Texas 78259 based company has been underperforming the oil & gas refining & marketing group over the past 52 weeks, with the stock losing -5.12%, compared to the industry which has advanced 12.97% over the same period. With RSI of 35.53, the stock should still continue to rise and get closer to its one year target estimate of $104.73, making it a hold for now.

Tesoro Corporation, through its subsidiaries, operates as an independent petroleum refining, logistics, and marketing company in the United States. Its Refining segment refines crude oil and other feed stocks into transportation fuels, such as gasoline, gasoline blend stocks, jet fuel, and diesel fuel, as well as other products, including heavy fuel oils, liquefied petroleum gas, petroleum coke, calcined coke, and asphalt. This segment also sells refined products in the wholesale market primarily through independent unbranded distributors; and in the bulk market primarily to independent unbranded distributors, other refining and marketing companies, utilities, railroads, airlines, marine, and industrial end-users in the western United States. It owns and operates 6 refineries with a combined crude oil capacity of approximately 875 thousand barrels per day. The company’s TLLP segment owns and operates a network of approximately 3,500 miles of crude oil, refined products, and natural gas pipelines; 29 crude oil and refined products truck and marine terminals; and approximately 15 million barrels of storage capacity. This segment also owns and operates four natural gas processing complexes and one fractionation facility. The company’s Marketing segment sells gasoline and diesel fuel through retail stations, and third-party branded dealers and distributors in the western United States. As of December 31, 2015, this segment operated a network of 2,397 retail stations under the ARCO, Shell, Exxon, Mobil, USA Gasoline, and Tesoro brands. The company was formerly known as Tesoro Petroleum Corporation and changed its name to Tesoro Corporation in November 2004. Tesoro Corporation was founded in 1968 and is headquartered in San Antonio, Texas.

Mead Johnson Nutrition Company (MJN) fell -0.53% during last trading as the stock lost $-0.4 to finish the day at $74.85 with about 2.54M shares changing hands, compared to its three month average trading volume of 1.96M. The $13.87B market cap company, which fluctuated between $73.52 and $76.02 during the day, currently situated 16.7% above its 52 week low of $65.53 and -19.83% away from its one year high of $94.4. The RSI of 67.27 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

Atwood Oceanics, Inc. (ATW) saw its value decrease by -1.44% as the stock dropped $-0.2 to finish the day at a closing price of $13.69. The stock was lighter in trading and has fluctuated between $4.82-$15.37 per share for the past year. The shares, which traded within a range of $13.65 to $14.1 during the day, are up by 49.29% in the past three months and up by 13.52% over the past six months. It is currently trading 1.6% above its 20 day moving average and 22.54% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $10.32 a share over the next twelve months. The current relative strength index (RSI) reading is 61.76. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.